Bausch Health Companies Inc. has announced the appointment of two new members to its Board of Directors, effective July 22, 2025. Michael Goettler, former CEO of Viatris, and Sandra Leung, former Executive Vice President and General Counsel of Bristol Myers Squibb Company, have joined the board, increasing its size from ten to twelve members. Goettler will serve on the Talent and Compensation Committee and Science and Technology Committee, while Leung will be part of the Nominating and Corporate Governance Committee.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Bausch Health Companies Inc. published the original content used to generate this news brief via ACCESS Newswire (Ref. ID: 1052125) on July 24, 2025, and is solely responsible for the information contained therein.